Related Experiment Videos
Extracorporeal Life Support Registry Report 1995
1University of Michigan Medical Center, Ann Arbor 48109-0331, USA.
Summary
The Extracorporeal Life Support Organization (ELSO) Registry Report shows 14,000 patients received life support. Survival rates are improving, with 80% survival in newborn respiratory failure cases.
Area of Science:
- Critical Care Medicine
- Pediatric Critical Care
- Neonatal Intensive Care
Background:
- The Extracorporeal Life Support Organization (ELSO) Registry collects data on patients undergoing extracorporeal life support (ELS).
- The 1995 report details outcomes for 14,000 patients treated with ELS.
- Respiratory failure is a primary indication for ELS across various age groups.
Purpose of the Study:
- To present the findings of the 1995 ELSO Registry Report.
- To analyze survival rates and trends in patients treated with extracorporeal life support.
- To highlight outcomes in specific patient populations, including neonates, pediatric, and adult patients with respiratory failure.
Main Methods:
- Data compilation from the ELSO Registry.
- Analysis of patient demographics, indications for ELS, and survival outcomes.
- Stratification of results by age group (newborn, pediatric, adult) and primary diagnosis (respiratory failure).
Main Results:
- A total of 14,000 patients treated with ELS were reported.
- Newborn infants with respiratory failure demonstrated a high survival rate of 80% (11,000 patients).
- Survival rates for pediatric and adult respiratory failure patients were 53% and 46%, respectively.
- The number of annual ELS cases plateaued between 1500-1800 per year around 1993.
- A gradual improvement in survival rates was observed in pediatric and adult respiratory cases.
Conclusions:
- Extracorporeal life support is a critical intervention for severe respiratory failure in neonates, with excellent survival outcomes.
- While survival rates for pediatric and adult respiratory failure patients are lower, there is evidence of gradual improvement.
- The ELSO Registry provides valuable data for monitoring trends and improving outcomes in ELS therapy.